What is the current target price for the Biofrontera share?

The average Biofrontera target price is €34.15. This is 10,572.80% higher than the current share price. 1 Analyst has issued a Biofrontera price target 2025.

How high will the Biofrontera share rise?

No reliable answer can be given as to how high the Biofrontera share will rise. The performance of shares, including the Biofrontera share, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Biofrontera share today?

The performance of Biofrontera shares on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Biofrontera share fall?

The decline in Biofrontera shares may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's share price could be in a certain period of time, usually 12 months.

Biofrontera Forecast, price target & analysts

€0.32

0.00%

Xetra, Thu, May 30 2024

ISIN

DE0006046113

Symbol

B8F

Index

CDAX

Sector

Health

Industry

Biotechnology

Overview Dividends Analysts Charts Strategies

Biofrontera Target price 2024 - Analyst rating & recommendation

Biofrontera Classifications & Recommendation:

Buy

100%

Biofrontera Target price

Target price	€34.15
Course	€0.32
Price potential	10,572.80% register free of charge
Number of estimates	1

	1 Analyst has issued a Biofrontera price target 2025. The average Biofrontera target price is €34.15. This is 10,572.80% register free of charge higher than the current share price.
	A rating was issued by 1 analysts: 1 Analysts recommend Biofrontera to buy, 0 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst estimates: Analysts believe that the Biofrontera share has an average upside potential 2025 of 10,572.80% register free of charge . Most analysts recommend the Biofrontera share at Purchase.

Discover more stocks with a high price target

Valneva 193.86%

CureVac N.V. 152.91%

Plug Power Inc. 106.89%

Bavarian Nordic 55.50%

Teamviewer 54.84%

Zalando 49.13%

Alibaba Group Holding Ltd 45.34%

Daimler Truck 44.32%

Register for free

StocksGuide is the tool for easily finding, analyzing and monitoring shares. Learn from successful investors and make well-founded investment decisions. We make you a self-determined investor.

Start now

The Apple share at a glance with charts, current key figures, news and share analyses.

The best dividend stocks in the dividend top scorer list.

Stock analyses of the best stocks worldwide.

Build wealth now